Molecular Cancer (Feb 2021)
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
- Wenfeng Fang,
- Haoxuan Jin,
- Huaqiang Zhou,
- Shaodong Hong,
- Yuxiang Ma,
- Yaxiong Zhang,
- Xiaofan Su,
- Longyun Chen,
- Yunpeng Yang,
- Shengqiang Xu,
- Yuwei Liao,
- Yuming He,
- Hongyun Zhao,
- Yan Huang,
- Zhibo Gao,
- Li Zhang
Affiliations
- Wenfeng Fang
- Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
- Haoxuan Jin
- Cancer Research Institute of YuceBio
- Huaqiang Zhou
- Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
- Shaodong Hong
- Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
- Yuxiang Ma
- Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
- Yaxiong Zhang
- Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
- Xiaofan Su
- Cancer Research Institute of YuceBio
- Longyun Chen
- Cancer Research Institute of YuceBio
- Yunpeng Yang
- Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
- Shengqiang Xu
- Cancer Research Institute of YuceBio
- Yuwei Liao
- Yangjiang Key Laboratory of Respiratory Diseases, Yangjiang People’s Hospital
- Yuming He
- YuceBio Technology Co., Ltd.
- Hongyun Zhao
- Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
- Yan Huang
- Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
- Zhibo Gao
- Cancer Research Institute of YuceBio
- Li Zhang
- Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
- DOI
- https://doi.org/10.1186/s12943-021-01331-9
- Journal volume & issue
-
Vol. 20,
no. 1
pp. 1 – 6
Abstract
No abstracts available.
